Early diagnosis of less survivable cancers could save 7,500 lives annually. The All-Party Parliamentary Group (APPG) on Less Survivable Cancers has released a pivotal report urging the UK Government to prioritise faster diagnosis of less survivable cancers, which include those of the brain, liver, lung, pancreas, oesophagus, and stomach. The report includes new analysis of existing […]
• The National Institute for Health and Care Excellence (NICE) has recommended the combination therapy of dabrafenib (Finlee®) and trametinib (Spexotras®) for the treatment of paediatric patients with low-grade glioma (LGG) and high-grade glioma (HGG) who have a BRAF V600E mutation. • BRAF V600E mutation is present in 15-20%2 of LGGs and in 5-10%3 of […]
Nanoparticles deliver brain cancer treatment: University of Queensland researchers have developed a nanoparticle to take a chemotherapy drug into fast growing, aggressive brain tumours. Research team lead Dr Taskeen Janjua from UQ’s School of Pharmacy said the new silica nanoparticle can be loaded with temozolomide, a small molecule drug used to treat tumours known as […]
Read More… from Nanoparticles deliver brain cancer treatment
A non-invasive Brain Cancer Treatment has been announced by Ivy Brain Tumor Center, SonALAsense and Insightec: The First Patient Dosed in First-in-Human Clinical Trial of Non-invasive Sonodynamic Therapy for the Treatment of Brain Cancer. The study combines metabolic targeting of glioblastoma with inert drug activated using MRI-guided focused ultrasound. The Ivy Brain Tumor Center at […]
Read More… from Non-invasive brain cancer treatment targeting glioblastoma
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, has announced the dosing of its first patient in a first-in-human Phase 0 clinical trial of sonodynamic therapy (SDT), a non invasive drug-device combination developed by SonALAsense in collaboration with Insightec. This historic study aims to develop […]
Read More… from First Patient in Historic First-in-Human Clinical Trial for Glioblastoma
Life-improving research for brain cancer survivors: Researchers will develop and demonstrate the impact of an online survivorship platform, co-produced with brain cancer survivors and carers, to streamline access to treating teams, peer support, and evidence-informed supportive care, in a private and secure environment. The University of Melbourne has welcomed an announcement by the Australian Government […]
Read More… from Life-improving research for brain cancer survivors
A study led by myself and my colleague Dr Sandrine Willaime-Morawek, lecturer in Stem Cells and Brain Repair at the University and published in Molecular Neurobiology, analysed how enzymes called ADAMs affect the movement and function of the human tumour cells which cause brain cancer. We discovered a potential way of stopping one of the most […]
Thirty years ago, being diagnosed with breast cancer was seen by many as a death sentence. Look how far we have come since then. According to the latest figures, 78 per cent of women are predicted to survive their disease for 10 years or more. In many other areas of cancer treatment, the improvements in […]